|
MEX3A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.104400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.118220E-01 |
| Normal-vs-Stage2 |
2.657000E-01 |
| Normal-vs-Stage3 |
2.416000E-01 |
| Normal-vs-Stage4 |
1.651190E-01 |
| Stage1-vs-Stage2 |
8.177800E-01 |
| Stage1-vs-Stage3 |
7.953800E-01 |
| Stage1-vs-Stage4 |
8.244400E-01 |
| Stage2-vs-Stage3 |
7.146000E-01 |
| Stage2-vs-Stage4 |
9.436000E-01 |
| Stage3-vs-Stage4 |
6.820600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.758630E-01 |
| Normal-vs-AfricanAmerican |
1.391210E-01 |
| Normal-vs-Asian |
1.196600E-01 |
| Caucasian-vs-AfricanAmerican |
3.448800E-01 |
| Caucasian-vs-Asian |
8.112000E-02 |
| AfricanAmerican-vs-Asian |
8.513200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.186100E-02 |
| Normal-vs-Female |
6.192000E-01 |
| Male-vs-Female |
6.602100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.359600E-03 |
| Normal-vs-Age(41-60Yrs) |
4.919900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.790000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.608400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.716640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.383000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.354600E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.796620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.596600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.144900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.844400E-02 |
| Normal-vs-Grade 2 |
8.510300E-02 |
| Normal-vs-Grade 3 |
2.292400E-01 |
| Normal-vs-Grade 4 |
1.535830E-01 |
| Grade 1-vs-Grade 2 |
1.975160E-01 |
| Grade 1-vs-Grade 3 |
2.158400E-01 |
| Grade 1-vs-Grade 4 |
2.139200E-01 |
| Grade 2-vs-Grade 3 |
6.436400E-01 |
| Grade 2-vs-Grade 4 |
9.615800E-01 |
| Grade 3-vs-Grade 4 |
6.849800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.182000E-01 |
| Normal-vs-ccB subtype |
1.819580E-02 |
| ccA subtype-vs-ccB subtype |
8.939000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.229200E-01 |
| Normal-vs-N1 |
1.637640E-01 |
| N0-vs-N1 |
2.670600E-01 |
|
|
